CEUFX
Price
$64.99
Change
+$0.86 (+1.34%)
Updated
Oct 20 closing price
Net Assets
137.06B
LAVGX
Price
$17.39
Change
+$0.22 (+1.28%)
Updated
Oct 20 closing price
Net Assets
3.83M
Interact to see
Advertisement

CEUFX vs LAVGX

Header iconCEUFX vs LAVGX Comparison
Open Charts CEUFX vs LAVGXBanner chart's image
American Funds EUPAC 529-F-1
Price$64.99
Change+$0.86 (+1.34%)
VolumeN/A
Net Assets137.06B
Lord Abbett International Growth R6
Price$17.39
Change+$0.22 (+1.28%)
VolumeN/A
Net Assets3.83M
CEUFX vs LAVGX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUFX has more cash in the bank: 137B vs. LAVGX (3.83M). CEUFX pays higher dividends than LAVGX: CEUFX (0.78) vs LAVGX (0.39). CEUFX was incepted earlier than LAVGX: CEUFX (23 years) vs LAVGX (4 years). LAVGX (9.10) is less costly to investors than CEUFX (0.91). LAVGX is a more actively managed with annual turnover of: 125.00 vs. CEUFX (35.00). LAVGX has a lower initial minimum investment than CEUFX: LAVGX (0) vs CEUFX (250). LAVGX annual gain was more profitable for investors over the last year : 18.04 vs. CEUFX (11.87).
CEUFXLAVGXCEUFX / LAVGX
Total Expense Ratio0.910.68134%
Annual Report Gross Expense Ratio0.919.1010%
Fund Existence23 years4 years-
Gain YTD23.20425.92390%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets137B3.83M3,577,023%
Annual Yield % from dividends0.780.39202%
Returns for 1 year11.8718.0466%
Returns for 3 years52.5874.4271%
Returns for 5 years17.18N/A-
Returns for 10 years54.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLX2.140.28
+15.05%
Protalix BioTherapeutics
CLPT27.321.94
+7.67%
ClearPoint Neuro
XENE43.441.81
+4.35%
Xenon Pharmaceuticals
PSIG4.030.01
+0.25%
PS International Group Ltd.
PHM123.27-1.18
-0.95%
Pultegroup